Cargando…
P-144: Response to SARS-CoV-2 vaccination in patients with Multiple Myeloma using a 12-week spaced dosing strategy
BACKGROUND: Evaluating the degree of protection afforded to multiple myeloma (MM) patients by vaccination against SARS-CoV-2 is of critical importance due to the high morbidity and mortality associated with infection and the immunosuppression associated with MM and its treatment. We have previously...
Autores principales: | Bird, Sarah, Panopoulou, Aikaterini, Shea, Robyn, Tsui, Micky, Saso, Radovan, Sud, Amit, West, Sharon, Smith, Katy, Barwood, John, Kaczmarek, Ewa, Panlaqui, Carmela, Kaiser, Martin, Stern, Simon, Boyd, Kevin, Pawlyn, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580189/ http://dx.doi.org/10.1016/S2152-2650(21)02271-0 |
Ejemplares similares
-
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
por: Bird, Sarah, et al.
Publicado: (2021) -
Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
por: Panopoulou, Aikaterini, et al.
Publicado: (2023) -
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial
por: Bird, Sarah, et al.
Publicado: (2021) -
Maintenance Strategies Post-Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
por: Bird, Sarah A., et al.
Publicado: (2020) -
Molecular profiling in myeloma
por: Pawlyn, Charlotte, et al.
Publicado: (2018)